United Therapeutics Corp
XNAS: UTHR
United Therapeutics Corp Live Stock Price Today, Share Analysis and Chart
about
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on...
Read More
490.83
-12.86
(-2.55%)
329.8K
XNAS Volume
XNAS 08 Jan, 2026 4:30 PM (EST)
Board Meeting
The next board meeting for United Therapeutics Corp is on 12 Jan 2026 for the purpose of 44th Annual J.P. Morgan Healthcare Conference
See details
High Financial Strength
Mid Valuation
Technically Moderately Bullish
Strong Performer, Getting Expensive
These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying
View Similar
Embed DVM
United Therapeutics Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..